- English
- Chinese
- French
- German
- Portuguese
- Spanish
- Russian
- Japanese
- Korean
- Arabic
- Irish
- Greek
- Turkish
- Italian
- Danish
- Romanian
- Indonesian
- Czech
- Afrikaans
- Swedish
- Polish
- Basque
- Catalan
- Esperanto
- Hindi
- Lao
- Albanian
- Amharic
- Armenian
- Azerbaijani
- Belarusian
- Bengali
- Bosnian
- Bulgarian
- Cebuano
- Chichewa
- Corsican
- Croatian
- Dutch
- Estonian
- Filipino
- Finnish
- Frisian
- Galician
- Georgian
- Gujarati
- Haitian
- Hausa
- Hawaiian
- Hebrew
- Hmong
- Hungarian
- Icelandic
- Igbo
- Javanese
- Kannada
- Kazakh
- Khmer
- Kurdish
- Kyrgyz
- Latin
- Latvian
- Lithuanian
- Luxembou..
- Macedonian
- Malagasy
- Malay
- Malayalam
- Maltese
- Maori
- Marathi
- Mongolian
- Burmese
- Nepali
- Norwegian
- Pashto
- Persian
- Punjabi
- Serbian
- Sesotho
- Sinhala
- Slovak
- Slovenian
- Somali
- Samoan
- Scots Gaelic
- Shona
- Sindhi
- Sundanese
- Swahili
- Tajik
- Tamil
- Telugu
- Thai
- Ukrainian
- Urdu
- Uzbek
- Vietnamese
- Welsh
- Xhosa
- Yiddish
- Yoruba
- Kinyarwanda
- Tatar
- Oriya
- Turkmen
- Uyghur
Izindaba
-
Izindaba
I-Inoperable Lung Cancer Treatment 2026: New TIL & Bispecific Breakthroughs
Okuqukethwe I-Paradigm Shift Ekwelapheni Okungasebenzeki Komdlavuza Wamaphaphu Ukuqonda I-Tumor-Infiltrating Lymphocyte (TIL) Therapy Bispecific Antibodies: The Dual-Target Approach Comparative Analysis of Eme...
Ukwelashwa Okuphindaphindiwe Komdlavuza Wamaphaphu 2026: Ukuphumelela Okusha Nemihlahlandlela Yakamuva
Ukuqonda Okuqukethwe Umdlavuza Wamaphaphu Ovela Kaningi ngo-2026 Imihlahlandlela Yakamuva ye-NCCN Yezindlela Zokwelapha Zomdlavuza Wamaphaphu Ongewona Amancane Amasu Amaqhinga Omdlavuza Wamaphaphu E-EGFR-Mutant Recu...
I-Indolent Lung Cancer Treatment 2026: Amaphrothokholi Amasha Okusinda Kwesikhathi Eside
Okuqukethwe Ukuqonda I-Indolent Lung Cancer ngo-2026 I-Paradigm Shift: Ukusuka Ekuhlinzweni Ngokushesha kuya Ekugadweni Okusebenzayo Izinketho Zokuhlinza Ezihlasela Kakhulu Zezilonda Eziqhubekayo Eziqhamukayo T...
Isigaba 2A Ukwelashwa Komdlavuza wamaphaphu 2026: Idatha entsha ye-ELCC ku-Neo-Adjuvant Therapy
Ukuqonda Okuqukethwe Isigaba 2A Umdlavuza Ongewona Owomncane Weseli Wamaphaphu 2026 ELCC Ukuphumelela Kumasu e-Neo-Adjuvant Amasu okwelapha aqondiswe ku-Driver-Mutated Stage 2A Ukuhlaziya Okuqhathaniswayo Komdlavuza Wamaphaphu kwe-Trea...
Isiteji Esibanzi Ukwelapha Umdlavuza Wamaphaphu Amangqamuzana Amancane 2026: Ukuphumelela Okusha kwe-Iza-bren ne-Tarlatamab
Okuqukethwe Ukuvela Kwesigaba Esibanzi Sokwelashwa Komdlavuza Wengqamuzana Encane I-Iza-bren: I-Paradigm Shift ku-Bispecific ADC Therapy Tarlatamab kanye Nokwanda Kokuphepha Nokubekezeleleka Kwe-T-Cell Engagers...
Ukwelashwa Okuphindaphindiwe Komdlavuza Wamaphaphu 2026: Ukuphumelela Okusha Nemihlahlandlela Yakamuva
Ukuqonda Okuqukethwe Umdlavuza Wamaphaphu Ovela Kaningi ngo-2026 Imihlahlandlela Yakamuva ye-NCCN Yezindlela Zokwelapha Zomdlavuza Wamaphaphu Ongewona Amancane Amasu Amaqhinga Omdlavuza Wamaphaphu E-EGFR-Mutant Recu...
